Is Wellbutrin (bupropion) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion (Wellbutrin) Safety During Pregnancy

Bupropion (Wellbutrin) should be used during pregnancy only if the benefits clearly outweigh the risks, as it is classified as FDA pregnancy Category C, indicating potential fetal risk. 1

Risk Assessment

Bupropion use during pregnancy presents several concerns:

  • Cardiac malformations: There is evidence suggesting a potential increased risk of cardiovascular defects, particularly left ventricular outflow tract obstruction and ventricular septal defects 1, 2
  • Spontaneous abortion: Higher rates of spontaneous abortions have been observed in women taking bupropion compared to control groups (p=0.009) 3
  • General safety concerns: Limited data exists on long-term outcomes for children exposed to bupropion in utero 4

Clinical Decision Algorithm

  1. Evaluate necessity of treatment:

    • Is the depression severe or recurrent? Only one meta-analysis provides limited evidence for preventing relapse in severe or recurrent depression 5
    • Are non-pharmacological approaches (psychotherapy) feasible as first-line treatment?
  2. Consider alternative medications:

    • Budesonide and prednisone are considered low risk in pregnancy 6
    • If medication is necessary, consider medications with better established safety profiles
  3. If bupropion is deemed necessary:

    • Use the lowest effective dose 1
    • Implement close maternal monitoring for depression symptoms 1
    • Arrange fetal cardiac monitoring 1
    • Consider gradual discontinuation before delivery to minimize neonatal effects 1

Monitoring Recommendations

If bupropion treatment is continued during pregnancy:

  • First trimester: Most critical period for potential cardiac malformations
  • Throughout pregnancy: Regular assessment of maternal mental health status
  • Before delivery: Consider tapering dose to minimize neonatal adaptation issues
  • Postpartum: Monitor infant for potential neurological symptoms if breastfeeding while taking bupropion 1

Important Caveats

  • Many pregnant women have heightened concerns about medication use during pregnancy, which may lead to poor adherence or abrupt discontinuation 7
  • Untreated depression during pregnancy carries its own risks to both mother and fetus
  • The absolute risk of congenital malformations with bupropion remains low, though higher than baseline 4
  • Most studies on bupropion in pregnancy have methodological limitations, including potential indication bias (whether used for depression or smoking cessation) 5, 4

Clinical Perspective

When counseling pregnant women about bupropion use:

  • Provide clear, evidence-based information about risks and benefits
  • Acknowledge that data is limited but concerning enough to warrant caution
  • Discuss alternative treatment options, including non-pharmacological approaches
  • If bupropion is continued, implement appropriate monitoring protocols
  • Document informed consent discussions thoroughly

The decision to use bupropion during pregnancy requires careful weighing of maternal mental health needs against potential fetal risks, with a preference for safer alternatives when possible.

References

Guideline

Medication Management for Mental Health Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bupropion (amfebutamone): caution during pregnancy.

Prescrire international, 2005

Research

Bupropion Use During Pregnancy: A Systematic Review.

The primary care companion for CNS disorders, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Perceptions of medicine use among pregnant women: an interview-based study.

International journal of clinical pharmacy, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.